BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 33959849)

  • 21. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers.
    Arora S; Khan S; Zaki A; Tabassum G; Mohsin M; Bhutto HN; Ahmad T; Fatma T; Syed MA
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):720-736. PubMed ID: 35257861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of chemokines in tumor growth.
    Raman D; Baugher PJ; Thu YM; Richmond A
    Cancer Lett; 2007 Oct; 256(2):137-65. PubMed ID: 17629396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of pancreatic cancer therapy resistance by chemokines.
    Gautam SK; Basu S; Aithal A; Dwivedi NV; Gulati M; Jain M
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):69-80. PubMed ID: 36064086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications.
    Maurya SK; Khan P; Rehman AU; Kanchan RK; Perumal N; Mahapatra S; Chand HS; Santamaria-Barria JA; Batra SK; Nasser MW
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):914-930. PubMed ID: 34968667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications.
    Mehraj U; Mushtaq U; Mir MA; Saleem A; Macha MA; Lone MN; Hamid A; Zargar MA; Ahmad SM; Wani NA
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):769-783. PubMed ID: 35278636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
    Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The good and the bad of chemokines/chemokine receptors in melanoma.
    Richmond A; Yang J; Su Y
    Pigment Cell Melanoma Res; 2009 Apr; 22(2):175-86. PubMed ID: 19222802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokines in tumor angiogenesis and metastasis.
    Singh S; Sadanandam A; Singh RK
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):453-67. PubMed ID: 17828470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.
    Mishra P; Banerjee D; Ben-Baruch A
    J Leukoc Biol; 2011 Jan; 89(1):31-9. PubMed ID: 20628066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokines: key players in cancer progression and metastasis.
    Singh R; Lillard JW; Singh S
    Front Biosci (Schol Ed); 2011 Jun; 3(4):1569-82. PubMed ID: 21622291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
    Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
    Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proprotein convertases: Key players in inflammation-related malignancies and metastasis.
    Siegfried G; Descarpentrie J; Evrard S; Khatib AM
    Cancer Lett; 2020 Mar; 473():50-61. PubMed ID: 31899298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utilization of chemokines to combat cancer: the double-edged sword.
    Dell'Agnola C; Biragyn A
    Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.
    Neo SY; Lundqvist A
    Adv Exp Med Biol; 2020; 1231():45-51. PubMed ID: 32060845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokines and the microenvironment in neuroectodermal tumor-host interaction.
    Somasundaram R; Herlyn D
    Semin Cancer Biol; 2009 Apr; 19(2):92-6. PubMed ID: 19049876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.
    Jin J; Zhao Q
    Theranostics; 2020; 10(14):6231-6244. PubMed ID: 32483450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment.
    O'Hayre M; Salanga CL; Handel TM; Allen SJ
    Biochem J; 2008 Feb; 409(3):635-49. PubMed ID: 18177271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.
    Yang L; Lin PC
    Semin Cancer Biol; 2017 Dec; 47():185-195. PubMed ID: 28782608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.
    Marcuzzi E; Angioni R; Molon B; Calì B
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.